Related Experiment Video
Updated: Jun 2, 2026

28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.4K
A Systematic Review of Delayed High-Grade Atrioventricular Block After Transcatheter Aortic Valve Implantation
Karan Rao1,2,3, Bernard Chan1,3, Alexandra Baer2
1Department of Cardiology, Royal North Shore Hospital, Sydney, Australia.
CJC Open
|April 8, 2024
Summary
Delayed high-grade atrioventricular block (HGAVB) after transcatheter aortic valve implantation (TAVI) occurs in 1.7%–14.6% of patients. Further research is needed to understand risk factors and implications of this serious complication.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- High-grade atrioventricular block (HGAVB) is a frequent complication following transcatheter aortic valve implantation (TAVI), often requiring permanent pacemaker (PPM) implantation.
- Delayed HGAVB, typically defined as occurring 48 hours post-TAVI or after discharge, presents a significant risk, potentially leading to syncope and sudden cardiac death.
Purpose of the Study:
- To estimate the incidence of delayed HGAVB after TAVI.
- To identify limitations in the current literature regarding delayed HGAVB.
Main Methods:
- A systematic review was conducted using Medline, Cochrane, Web of Science, and Scopus databases.
- Studies focusing on "delayed" or "late" atrioventricular block post-TAVI were included, excluding patients with prior PPM or aortic valve surgery.
- The initial search identified 775 studies, with 19 ultimately included after screening.
Main Results:
- The review included 19 studies encompassing 14,898 patients, with a mean age of 81.7 years and 46.3% males.
- The incidence of delayed HGAVB varied widely, ranging from 1.7% to 14.6% across the studies.
- Significant methodologic heterogeneity was observed among the included studies, impacting the reliability of the reported incidence rates.
Conclusions:
- Delayed HGAVB is a recognized and potentially severe complication of TAVI, sharing risk factors with acute HGAVB.
- The increasing trend towards early discharge post-TAVI necessitates further prospective research.
- Future studies should aim to enhance the understanding of predisposing factors, precise incidence, timing, and clinical implications of delayed HGAVB.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

